查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1322230

面部注射剂市场 - 全球行业分析、规模、份额、增长、趋势和预测，2023-2031 年

Facial Injectables Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

面部注射剂市场 - 报告范围

TMR 关于全球面部注射剂市场的报告研究了过去以及当前的增长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球面部注射剂市场的收入2017-2031年期间，考虑2023年为基准年，2031年为预测年。该报告还提供了2023年至2031年全球面部注射剂市场的复合年增长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领袖和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解面部注射剂市场。

该报告深入研究了全球面部注射剂市场的竞争格局。全球面部注射剂市场的主要参与者已经确定，并且每一位参与者都根据各种属性进行了分析。公司概述、财务状况、最新发展和 SWOT 是本报告中介绍的全球面部注射市场参与者的属性。

目录

第一章：前言

第 2 章：假设和研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2017-2031年全球市场分析与预测
  • 波特五力分析

第 5 章：关键见解

  • 技术进步
  • 定价分析
  • 主要併购
  • 市场空间中排名前三的参与者
  • COVID-19 大流行对行业的影响（价值炼和短期/中期/长期影响）

第 6 章：全球市场分析与预测：按产品类型

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按产品类型，2017-2031
    • 胶原
    • 透明质酸 (HA)
    • A型肉毒桿菌毒素
    • 羟基磷灰石钙 (CaHA)
    • 聚甲基丙烯酸甲酯珠（PMMA微球）
    • 聚左旋乳酸 (PLLA)
    • 其他（聚烷基酰亚胺）
  • 市场吸引力分析：按产品类型

第 7 章：全球市场分析与预测：按应用分类

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按应用分类，2017-2031
    • 面部线条矫正
    • 丰唇术
    • 痤疮疤痕治疗
    • 面部提升
    • 脂肪萎缩治疗
    • 其他（耳垂回春）
  • 市场吸引力分析：按应用

第 8 章：全球市场分析与预测：按最终用户

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2017-2031
    • 医院
    • 皮肤科诊所
    • 其他（美容诊所）
  • 市场吸引力分析：按最终用户

第 9 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2017-2031
    • 北美
    • 欧洲
    • 亚太地区
    • 拉美
    • 中东和非洲
  • 市场吸引力分析：按地区

第 10 章：北美市场分析与预测

第 11 章：欧洲市场分析与预测

第 12 章：亚太市场分析与预测

第 13 章：拉丁美洲市场分析与预测

第 14 章：中东和非洲市场分析与预测

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（按公司层级和规模）
  • 市场份额分析：按公司划分（2021 年）
  • 公司简介
    • Allergan, Inc.
    • Ipsen (Mayroy SA)
    • Merz Pharma
    • Suneva Medical, Inc.
    • Medytox Inc.
    • Sinclair Pharma
    • Bloomage BioTechnology
    • Anika Therapeutics, Inc.
    • Prollenium Medical Technologies
    • Galderma
Product Code: TMRGL1779

Facial Injectables Market - Scope of Report

TMR's report on the global Facial Injectables Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Facial Injectables Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Facial Injectables Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Facial Injectables Market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Facial Injectables Market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Facial Injectables Market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Facial Injectables Market.

The report delves into the competitive landscape of the global Facial Injectables Market. Key players operating in the global Facial Injectables Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Facial Injectables Market profiled in this report.

Key Questions Answered in Global Facial Injectables Market Report:

  • What is the sales/revenue generated by mobile photo printer across all regions during the forecast period?
  • What are the opportunities in the global Facial Injectables Market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Facial Injectables Market - Research Objectives and Research Approach

The comprehensive report on the global Facial Injectables Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Facial Injectables Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Facial Injectables.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Facial Injectables Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Facial Injectables Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)
    • 4.4.2. Market Volume/Unit Shipments Projections
  • 4.5. Porter's Five Forces Analysis

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. Pricing Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. Top 3 Players Operating in the Market Space
  • 5.5. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global Facial Injectables Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2031
    • 6.3.1. Collagen
    • 6.3.2. Hyaluronic Acid (HA)
    • 6.3.3. Botulinum Toxin Type A
    • 6.3.4. Calcium Hydroxylapatite (CaHA)
    • 6.3.5. Polymethylmethacrylate Beads (PMMA Microspheres)
    • 6.3.6. Poly-L-Lactic Acid (PLLA)
    • 6.3.7. Others (Polyalkylimide )
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Facial Injectables Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Facial Line Correction
    • 7.3.2. Lip Augmentation
    • 7.3.3. Acne Scar Treatment
    • 7.3.4. Face Lift
    • 7.3.5. Lipoatrophy Treatment
    • 7.3.6. Others (earlobe rejuvenation)
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Facial Injectables Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals
    • 8.3.2. Dermatology Clinics
    • 8.3.3. Others (beauty clinics)
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Facial Injectables Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Facial Injectables Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product Type, 2017-2031
    • 10.2.1. Collagen
    • 10.2.2. Hyaluronic Acid (HA)
    • 10.2.3. Botulinum Toxin Type A
    • 10.2.4. Calcium Hydroxylapatite (CaHA)
    • 10.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
    • 10.2.6. Poly-L-Lactic Acid (PLLA)
    • 10.2.7. Others (Polyalkylimide)
  • 10.3. Market Value Forecast, by Application, 2017-2031
    • 10.3.1. Facial Line Correction
    • 10.3.2. Lip Augmentation
    • 10.3.3. Acne Scar Treatment
    • 10.3.4. Face Lift
    • 10.3.5. Lipoatrophy Treatment
    • 10.3.6. Others (earlobe rejuvenation)
  • 10.4. Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Hospitals
    • 10.4.2. Dermatology Clinics
    • 10.4.3. Others (Beauty Clinics)
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Facial Injectables Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2017-2031
    • 11.2.1. Collagen
    • 11.2.2. Hyaluronic Acid (HA)
    • 11.2.3. Botulinum Toxin Type A
    • 11.2.4. Calcium Hydroxylapatite (CaHA)
    • 11.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
    • 11.2.6. Poly-L-Lactic Acid (PLLA)
    • 11.2.7. Others (Polyalkylimide)
  • 11.3. Market Value Forecast, by Application, 2017-2031
    • 11.3.1. Facial Line Correction
    • 11.3.2. Lip Augmentation
    • 11.3.3. Acne Scar Treatment
    • 11.3.4. Face Lift
    • 11.3.5. Lipoatrophy Treatment
    • 11.3.6. Others (earlobe rejuvenation)
  • 11.4. Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Hospitals
    • 11.4.2. Dermatology Clinics
    • 11.4.3. Others (beauty clinics)
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Facial Injectables Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2017-2031
    • 12.2.1. Collagen
    • 12.2.2. Hyaluronic Acid (HA)
    • 12.2.3. Botulinum Toxin Type A
    • 12.2.4. Calcium Hydroxylapatite (CaHA)
    • 12.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
    • 12.2.6. Poly-L-Lactic Acid (PLLA)
    • 12.2.7. Others (Polyalkylimide)
  • 12.3. Market Value Forecast, by Application, 2017-2031
    • 12.3.1. Facial Line Correction
    • 12.3.2. Lip Augmentation
    • 12.3.3. Acne Scar Treatment
    • 12.3.4. Face Lift
    • 12.3.5. Lipoatrophy Treatment
    • 12.3.6. Others (earlobe rejuvenation)
  • 12.4. Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Hospitals
    • 12.4.2. Dermatology Clinics
    • 12.4.3. Others (beauty clinics)
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Facial Injectables Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2017-2031
    • 13.2.1. Collagen
    • 13.2.2. Hyaluronic Acid (HA)
    • 13.2.3. Botulinum Toxin Type A
    • 13.2.4. Calcium Hydroxylapatite (CaHA)
    • 13.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
    • 13.2.6. Poly-L-Lactic Acid (PLLA)
    • 13.2.7. Others (Polyalkylimide)
  • 13.3. Market Value Forecast, by Application, 2017-2031
    • 13.3.1. Facial Line Correction
    • 13.3.2. Lip Augmentation
    • 13.3.3. Acne Scar Treatment
    • 13.3.4. Face Lift
    • 13.3.5. Lipoatrophy Treatment
    • 13.3.6. Others (earlobe rejuvenation)
  • 13.4. Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Hospitals
    • 13.4.2. Dermatology Clinics
    • 13.4.3. Others (beauty clinics)
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Facial Injectables Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2017-2031
    • 14.2.1. Collagen
    • 14.2.2. Hyaluronic Acid (HA)
    • 14.2.3. Botulinum Toxin Type A
    • 14.2.4. Calcium Hydroxylapatite (CaHA)
    • 14.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
    • 14.2.6. Poly-L-Lactic Acid (PLLA)
    • 14.2.7. Others (Polyalkylimide)
  • 14.3. Market Value Forecast, by Application, 2017-2031
    • 14.3.1. Facial Line Correction
    • 14.3.2. Lip Augmentation
    • 14.3.3. Acne Scar Treatment
    • 14.3.4. Face Lift
    • 14.3.5. Lipoatrophy Treatment
    • 14.3.6. Others (earlobe rejuvenation)
  • 14.4. Market Value Forecast, by End-user, 2017-2031
    • 14.4.1. Hospitals
    • 14.4.2. Dermatology Clinics
    • 14.4.3. Others (beauty clinics)
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company (2021)
  • 15.3. Company Profiles
    • 15.3.1. Allergan, Inc.
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Ipsen (Mayroy SA)
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Merz Pharma
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Suneva Medical, Inc.
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Medytox Inc.
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Sinclair Pharma
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Bloomage BioTechnology
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Anika Therapeutics, Inc.
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Prollenium Medical Technologies
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
    • 15.3.10. Galderma
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Facial Injectables Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global Facial Injectables Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 03: Global Facial Injectables Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Facial Injectables Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Facial Injectables Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Facial Injectables Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 07: North America Facial Injectables Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 08: North America Facial Injectables Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Facial Injectables Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Facial Injectables Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 11: Europe Facial Injectables Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 12: Europe Facial Injectables Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Asia Pacific Facial Injectables Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Facial Injectables Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 15: Asia Pacific Facial Injectables Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 16: Asia Pacific Facial Injectables Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Latin America Facial Injectables Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Facial Injectables Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 19: Latin America Facial Injectables Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 20: Latin America Facial Injectables Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Middle East & Africa Facial Injectables Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Facial Injectables Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 23: Middle East & Africa Facial Injectables Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 24: Middle East & Africa Facial Injectables Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Facial Injectables Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Facial Injectables Market Value Share, by Product Type, 2022
  • Figure 03: Global Facial Injectables Market Value Share, by Application, 2022
  • Figure 04: Global Facial Injectables Market Value Share, by End-user, 2022
  • Figure 05: Global Facial Injectables Market Value Share, by Region, 2022
  • Figure 06: Global Facial Injectables Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 07: Global Facial Injectables Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 08: Global Facial Injectables Market Revenue (US$ Mn), by Collagen, 2017-2031
  • Figure 09: Global Facial Injectables Market Revenue (US$ Mn), by Hyaluronic Acid (HA), 2017-2031
  • Figure 10: Global Facial Injectables Market Revenue (US$ Mn), by Botulinum Toxin Type A, 2017-2031
  • Figure 11: Global Facial Injectables Market Revenue (US$ Mn), by Calcium Hydroxylapatite (CaHA), 2017-2031
  • Figure 12: Global Facial Injectables Market Revenue (US$ Mn), by Polymethylmethacrylate Beads (PMMA Microspheres), 2017-2031
  • Figure 13: Global Facial Injectables Market Revenue (US$ Mn), by Poly-L-Lactic Acid (PLLA), 2017-2031
  • Figure 14: Global Facial Injectables Market Revenue (US$ Mn), by Others (Polyalkylimide), 2017-2031
  • Figure 15: Global Facial Injectables Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 16: Global Facial Injectables Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 17: Global Facial Injectables Market Revenue (US$ Mn), by Facial Line Correction, 2017-2031
  • Figure 18: Global Facial Injectables Market Revenue (US$ Mn), by Lip Augmentation, 2017-2031
  • Figure 19: Global Facial Injectables Market Revenue (US$ Mn), by Acne Scar Treatment, 2017-2031
  • Figure 20: Global Facial Injectables Market Revenue (US$ Mn), by Face Lift, 2017-2031
  • Figure 21: Global Facial Injectables Market Revenue (US$ Mn), by Lipoatrophy Treatment, 2017-2031
  • Figure 22: Global Facial Injectables Market Revenue (US$ Mn), by Others (earlobe rejuvenation), 2017-2031
  • Figure 23: Global Facial Injectables Market Value Share Analysis, by End-user, 2017-2031
  • Figure 24: Global Facial Injectables Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 25: Global Facial Injectables Market Revenue (US$ Mn), by Hospitals, 2017-2031
  • Figure 26: Global Facial Injectables Market Revenue (US$ Mn), by Dermatology Clinics, 2017-2031
  • Figure 27: Global Facial Injectables Market Revenue (US$ Mn), by Others (beauty clinics), 2017-2031
  • Figure 28: Global Facial Injectables Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 29: Global Facial Injectables Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 30: North America Facial Injectables Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 31: North America Facial Injectables Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 32: North America Facial Injectables Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 33: North America Facial Injectables Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 34: North America Facial Injectables Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 35: North America Facial Injectables Market Value Share Analysis (US$ Mn), by Application, 2017-2031
  • Figure 36: North America Facial Injectables Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 37: North America Facial Injectables Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 38: North America Facial Injectables Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 39: Europe Facial Injectables Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 40: Europe Facial Injectables Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 41: Europe Facial Injectables Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 42: Europe Facial Injectables Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 43: Europe Facial Injectables Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 44: Europe Facial Injectables Market Value Share Analysis, by Application, 2017-2031
  • Figure 45: Europe Facial Injectables Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 46: Europe Facial Injectables Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 47: Europe Facial Injectables Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 48: Asia Pacific Facial Injectables Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 49: Asia Pacific Facial Injectables Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 50: Asia Pacific Facial Injectables Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 51: Asia Pacific Facial Injectables Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 52: Asia Pacific Facial Injectables Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 53: Asia Pacific Facial Injectables Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 54: Asia Pacific Facial Injectables Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 55: Asia Pacific Facial Injectables Market Value Share Analysis, by End-user, 2017-2031
  • Figure 56: Asia Pacific Facial Injectables Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 57: Latin America Facial Injectables Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 58: Latin America Facial Injectables Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 59: Latin America Facial Injectables Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 60: Latin America Facial Injectables Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 61: Latin America Facial Injectables Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 62: Latin America Facial Injectables Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 63: Latin America Facial Injectables Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 64: Latin America Facial Injectables Market Value Share Analysis, by End-user, 2017-2031
  • Figure 65: Latin America Facial Injectables Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 66: Middle East & Africa Facial Injectables Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 67: Middle East & Africa Facial Injectables Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 68: Middle East & Africa Facial Injectables Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 69: Middle East & Africa Facial Injectables Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 70: Middle East & Africa Facial Injectables Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 71: Middle East & Africa Facial Injectables Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 72: Middle East & Africa Facial Injectables Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 73: Middle East & Africa Facial Injectables Market Value Share Analysis, by End-user, 2017-2031
  • Figure 74: Middle East & Africa Facial Injectables Market Attractiveness Analysis, by End-user, 2023-2031